The stock holds no value, and the monitor has said so in their 10th and 11th reports. The general rules and things that the various companies can do in CCAA are no longer an option for BioAmber. They liquidated the assets, and that is clearly documented and absolutely undeniable. There’s nothing left but an empty shell with massive debt. This company is toast when it returns to the US courts, as the judge will have no choice but to discharge the remaining debt and equity (the stock) and close BioAmber for good.
Shareholders will lose 100% of their investment in this stock.